Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Jun 29, 2023 (Full proposal)

Later deadlines: May 13, 2024 (Full proposal), Jun 13, 2024 (Full proposal), May 13, 2025 (Letter of inquiry), Jun 13, 2025 (Full proposal)

Grant amount: Up to US $1,550,000

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization. 

The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer interception and prevention.

• Purpose of UG3: Select clinically relevant targets and develop and validate assays for bioactivity as well as toxicity screening 
• Purpose of UH3 phase: Screening libraries, structure elucidation, full-scale characterization, efficacy testing, and development of the screened agents.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.